PubMed HealthSearch

PubMed · 3292284

Phospholipid flippases.

Abstract

Protein mediated phospholipid translocation through membranes has been observed in rat liver endoplasmic reticulum and in the plasma membrane of erythrocytes as well as in a few other cell membranes. Lipid translocation in plasma membranes is ATP dependent and selectively accumulates aminophospholipids on the inner monolayers.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P F Devaux. 1988-07-04. Phospholipid flippases.. https://doi.org/10.1016/0014-5793(88)81291-2

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The human mitochondrial genome contains a second light strand promoter.

The human mitochondrial genome must be replicated and expressed in a timely manner to maintain energy metabolism and supply cells with adequate levels of adenosine triphosphate. Central to this process is the idea that replication primers and gene products both arise via transcription from a single light strand promoter (LSP) such that primer formation can influence gene expression, with no consensus as to how this is regulated. Here, we report the discovery of a second light strand promoter (LSP2) in humans, with features characteristic of a bona fide mitochondrial promoter. We propose that the position of LSP2 on the mitochondrial genome allows replication and gene expression to be orchestrated from two distinct sites, which expands our long-held understanding of mitochondrial gene expression in humans.

Adenosine Triphosphate

GCN2 kinase activation by ATP-competitive kinase inhibitors.

Small-molecule kinase inhibitors represent a major group of cancer therapeutics, but tumor responses are often incomplete. To identify pathways that modulate kinase inhibitor response, we conducted a genome-wide knockout (KO) screen in glioblastoma cells treated with the pan-ErbB inhibitor neratinib. Loss of general control nonderepressible 2 (GCN2) kinase rendered cells resistant to neratinib, whereas depletion of the GADD34 phosphatase increased neratinib sensitivity. Loss of GCN2 conferred neratinib resistance by preventing binding and activation of GCN2 by neratinib. Several other Food and Drug Administration (FDA)-approved inhibitors, such erlotinib and sunitinib, also bound and activated GCN2. Our results highlight the utility of genome-wide functional screens to uncover novel mechanisms of drug action and document the role of the integrated stress response (ISR) in modulating the response to inhibitors of oncogenic kinases.

Adenosine Triphosphate

Nitric oxide-independent effects of nitric oxide donors on energy metabolism in erythrocytes.

In order to study the roles of nitric oxide (NO) in various biological events, several types of NO-releasing agents have been extensively used. Although both NO and its donors and/or their decomposed products may have biological activities, most of the cellular responses to these donors have been postulated to reflect NO-dependent events. Among the various NO donors, 1-hydroxy-2-oxo-3-(N-methyl-aminopropyl)-3-methyl-l-triazene (NOC7), 3-morpholinosydnonimine N-ethylcarbamide (SIN-1), S-nitrosoglutathione, S-nitrosocysteine (CysNO), and related nitrosothiols are commonly used agents. To investigate the biological activities of these donors and their decomposed products, we tested their effects on energy metabolism in erythrocytes. When incubated with freshly prepared erythrocytes, NOC7, Cys-NO, and their decomposed products, but not NO and its oxidized metabolites, nitrite and nitrate, decreased cellular ATP levels. Although SIN-1 generates both NO and superoxide radical thereby forming peroxynitrite (ONOO-), this donor had no appreciable effect on cellular ATP levels, even in the presence of superoxide dismutase. These results indicate that NOC7 and CysNO and/or their decomposed product(s), but not NO and its oxidized metabolites, are responsible for the decrease in cellular ATP levels. Thus, the effects of not only NO and its oxidized metabolites (NO2, NO3 ), but also NO donors and their decomposed products, should be taken into account when attempting to understand the mechanism of biological responses induced by NO donors.

Adenosine Triphosphate